Precision BioSciences, Inc. - Common Stock (NQ:DTIL)

6.400 -0.240 (-3.61%)

Delayed Quote Updated: 3:51 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Precision BioSciences, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Precision BioSciences Presents Analysis of Azer-Cel, Allogeneic CAR T Product Attributes Related to In Vivo Pharmacokinetics, Pharmacodynamics, and Clinical Outcomes at 2022 American Society of Hematology Annual Meeting

December 10, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Earnings Perspective: Return On Capital Employed ↗

December 06, 2022

Via Benzinga

Precision BioSciences Announces Change to its Board of Directors

November 10, 2022

From Precision BioSciences, Inc.

Via Business Wire

Coinbase To $80? Plus Deutsche Bank Cuts PT On This Stock By 80% ↗

November 10, 2022

Citigroup cut the price target on Coinbase Global, Inc. (NASDAQ: COIN) from $105 to $80. Citigroup analyst Peter Christiansen maintained a Buy rating on the stock. Coinbase shares rose 2.1% to $46.95...

Via Benzinga

Precision BioSciences Reports Third Quarter 2022 Financial Results and Provides Business Update

November 08, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences's Earnings Outlook ↗

November 07, 2022

Precision BioSciences (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

November 04, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Announces Data Presentation on Effective Cell Dose and Functional Attributes of CD19 Allogeneic CAR T, Azer-Cel, at the Upcoming 2022 American Society of Hematology (ASH) Annual Meeting

November 03, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences to Report Third Quarter 2022 Financial Results on November 8, 2022

November 02, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)

October 26, 2022

From Precision BioSciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 18, 2022

Gainers

Via Benzinga

Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th Congress

October 11, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences to Participate in Upcoming Jefferies Cell & Genetic Medicine Summit

September 22, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences to Participate in Upcoming H.C. Wainwright 24th Annual Global Investment Conference

September 07, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Announces Senior Leadership Organizational Changes

September 02, 2022

From Precision BioSciences, Inc.

Via Business Wire

Looking Into Precision BioSciences, Inc. - Common Stock's Return On Capital Employed ↗

August 30, 2022

Benzinga Pro data, Precision BioSciences, Inc. - Common Stock (NASDAQ:DTIL) reported Q2 sales of $3.82 million. Earnings fell to a loss of $31.04 million, resulting in a 10.18% decrease from last...

Via Benzinga

Precision BioSciences: Q2 Earnings Insights ↗

August 08, 2022

Precision BioSciences (NASDAQ:DTIL) reported its Q2 earnings results on Monday, August 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Precision BioSciences Reports Second Quarter 2022 Financial Results and Provides Business Update

August 08, 2022

From Precision BioSciences, Inc.

Via Business Wire

Earnings Preview: Precision BioSciences, Inc. - Common Stock ↗

August 05, 2022

Precision BioSciences, Inc. - Common Stock (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement.

Via Benzinga

Precision BioSciences to Report Second Quarter 2022 Financial Results on August 8, 2022

August 01, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

July 25, 2022

From Precision BioSciences, Inc.

Via Business Wire

Global Pancreatic Cancer Therapeutics & Diagnostics Market Expected To Reach $5.6 Billion By 2027

June 28, 2022

Palm Beach, FL – June 28, 2022 – FinancialNewsMedia.com News Commentary – Pancreatic cancer therapeutics and diagnostics involve medical procedures used to diagnose pancreatic cancer and subsequent...

Via FinancialNewsMedia

Precision BioSciences Announces Closing of Underwritten Offering of Common Stock

June 27, 2022

From Precision BioSciences, Inc.

Via Business Wire

This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday ↗

June 28, 2022

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More ↗

June 23, 2022

Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.

Via Benzinga

40 Stocks Moving In Wednesday's Mid-Day Session ↗

June 22, 2022

Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares jumped 116.6% to $12.82 after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.

Via Benzinga

Exela Technologies (XELA) Stock Soars After Securing $136 Million Contract ↗

June 22, 2022

Exela Technologies (XELA) stock is taking off on Wednesday after gaining a new $136 million customer contract that lasts for three years.

Via InvestorPlace

Athira Pharma (ATHA) Stock Plunges 65% on Disappointing Drug Trial Results ↗

June 22, 2022

Athira Pharma (ATHA) stock is plummeting on Wednesday following the outcome of a Phase 2 clinical trial of fosgonimeton.

Via InvestorPlace

Precision BioSciences (DTIL) Stock Treks Higher on Novartis Deal ↗

June 22, 2022

DTIL stock is advancing in early trading today after Precision BioScience announced a partnership with Novartis, a leading drug maker.

Via InvestorPlace

Futures, Oil Tumble As Attention Turns To Coming Recession, Powell Senate Testimony ↗

June 22, 2022

Tuesday's euphoric market mood has U-turned into sheer despair with most of yesterday's gains gone overnight as attention turns to the coming US recession.

Via Talk Markets

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.